Continuing Medical Education and Self Assessment Modules:  Meetings,  Webinars,  and  Self  Study  Courses
Sign Up    Log In    Home 


Emerging and Re-Emerging Infectious Diseases
Wednesday, December 3, 2014 - Wednesday, December 3, 2014
    Share

CME Provider:
University Learning Systems ›
Stephanie Naski
PO Box 35
East Amherst, New York (NY) 14051
United States
 
Toll Free: 1-800-940-5860
Phone: 716-529-0472
Fax: 716-529-0550
 
Visit the CME Provider Webpage ›
 

Conference Center:
Harrah's Las Vegas ›
3475 Las Vegas Boulevard South
Las Vegas, Nevada (NV) 89109
United States
 
Phone: (800) 214-9110
 
Visit the Conference Center Webpage ›
 

Description:
At the end of the continuing education sessions, the participant should be able to:

Define emerging and re-emerging infectious diseases and list numerous examples of emerging and re-emerging infectious diseases as defined by the Centers for Disease Control and Prevention.

Discuss the factors contributing to the emergence and re-emergence of infectious diseases and explain the role of each factor in emergence and re-emergence.

Review the prevalence of vaccine-preventable diseases (e.g., measles, diphtheria, influenza, pertussis) in the United States and discuss the societal risks of lack of vaccination for these diseases.

Identify signs and symptoms of vaccine-preventable diseases in a given patient and develop treatment and prevention plans for these patients.

List the urgent and serious antimicrobial resistance threats in the United States and risk factors for emergence of resistance.

Understand the mechanism of antibiotic resistance in Neiserria gonorrhoeae and how emergence of resistance has resulted in limitations of treatment options for patients with gonorrhea.

Compare and contrast the differences between community-associated and hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and develop treatment plans for patients with infections caused by community-associated MRSA.

Discuss the prevalence, treatment, and steps to prevention of infections with Clostridium difficile.

Discuss the role of antimicrobial stewardship in the health institutions and the community.

Define multidrug-resistant, extensively drug-resistant, and total drug-resistant tuberculosis and develop treatment plans for patients with tuberculosis.
Review the prevalence, clinical presentation, and outcomes for infections other emerging infectious diseases, including Ebola, dengue fever, West Nile Virus, Middle East Respiratory Syndrome (MERS), avian influenza A (H7N9), and Naegleria fowleri (brain-eating ameba).

Review strategies developed by the Centers for Disease Control and Prevention and its international partners to prevent emergence and global spread of infectious diseases.
 
Visit the CME Course Webpage ›
 
 
Instructors:
Michael B. Kays, Pharm.D., FCCP
Associate Professor of Pharmacy Practice
Purdue University College of Pharmacy
Adjunct Associate Professor of Medicine
Indiana University School of Medicine
West Lafayette and Indianapolis, Indiana
 
 
CME Credit:
Physicians:  5.00 Hours
Physician Assistants:  5.00 Hours
Nurses:  .5 Hours

Self Assessment Module (SAM):  No

Specialty Audience:
Family Medicine    Internal Medicine    

CME Sam Course #9186

Map of Harrah's Las Vegas, 3475 Las Vegas Boulevard South, Las Vegas, Nevada (NV), United States
 
 
Show Nearby:     Rank By: 
 
 


Healthcare Professionals     CME Providers     Advertise     About Us

Terms of Use     Privacy Policy


Copyright © 2013 Maxwell Publishing Company. All rights reserved.
The CME Sam logo and 'What's News In CME' are registered U.S. trademarks.
Follow Us


     
CME Sam